Ho SB

Samuel B. Ho, MD

Samuel B. Ho, MD

Samuel B. Ho, MD

Samuel B. Ho, MD

Samuel B. Ho, MD

Samuel B. Ho, MD

VA National Hepatitis C Program of the Public Health Strategic Health Care Group: Michael Rigsby, MD (director), Jane Burgess, ACRN, MS, Victoria Davey, RN, MPH, Connie Raab, and Lawrence R. Deyton, MSPH, MD (chief consultant); VA Hepatitis C Resource Centers: Teresa L. Wright, MD, Helen Yee, PharmD, Samuel B. Ho, MD, Guadalupe Garcia-Tsao, MD, and Jason A. Dominitz, MD, MHS; and the VA Hepatitis C Technical Advisory Group: Garth Austin, MD, PhD, Joseph Awad, MD, Edmund Bini, MD, FACP, FACG, Lynn Bradley, PA, Robert Dufour, MD, Judith Feldman, MD, MPH, Katherine P. Frandsen, RN, CIC, Curt Hagedorn, MD, Rhonda Jankovich, RN, BSN, Karen Jones, Linda Jones, MSN-RN, Stephen Kendall, Daniel Kivlahan, PhD, Kathy Lockhart, RN, MSN, MPA, Thomas Mahl, MD, Robert McNamara, Shvawn McPherson-Baker, PhD, Timothy Morgan, MD, Linda Rabeneck, MD, David Rimland, MD, Gary Roselle, MD, Hugo Rosen, MD, Kimberly Summers, PhD, and Michael Valentino, RPh.

Dr. Wright has led development of the treatment recommendations since their inception. She and Dr. Yee are the lead authors of this version.

VA National Hepatitis C Program of the Public Health Strategic Health Care Group: Michael Rigsby, MD (director), Jane Burgess, ACRN, MS, Victoria Davey, RN, MPH, Connie Raab, and Lawrence R. Deyton, MSPH, MD (chief consultant); VA Hepatitis C Resource Centers: Teresa L. Wright, MD, Helen Yee, PharmD, Samuel B. Ho, MD, Guadalupe Garcia-Tsao, MD, and Jason A. Dominitz, MD, MHS; and the VA Hepatitis C Technical Advisory Group: Garth Austin, MD, PhD, Joseph Awad, MD, Edmund Bini, MD, FACP, FACG, Lynn Bradley, PA, Robert Dufour, MD, Judith Feldman, MD, MPH, Katherine P. Frandsen, RN, CIC, Curt Hagedorn, MD, Rhonda Jankovich, RN, BSN, Karen Jones, Linda Jones, MSN-RN, Stephen Kendall, Daniel Kivlahan, PhD, Kathy Lockhart, RN, MSN, MPA, Thomas Mahl, MD, Robert McNamara, Shvawn McPherson-Baker, PhD, Timothy Morgan, MD, Linda Rabeneck, MD, David Rimland, MD, Gary Roselle, MD, Hugo Rosen, MD, Kimberly Summers, PhD, and Michael Valentino, RPh.

Dr. Wright has led development of the treatment recommendations since their inception. She and Dr. Yee are the lead authors of this version.

VA National Hepatitis C Program of the Public Health Strategic Health Care Group: Michael Rigsby, MD (director), Jane Burgess, ACRN, MS, Victoria Davey, RN, MPH, Connie Raab, and Lawrence R. Deyton, MSPH, MD (chief consultant); VA Hepatitis C Resource Centers: Teresa L. Wright, MD, Helen Yee, PharmD, Samuel B. Ho, MD, Guadalupe Garcia-Tsao, MD, and Jason A. Dominitz, MD, MHS; and the VA Hepatitis C Technical Advisory Group: Garth Austin, MD, PhD, Joseph Awad, MD, Edmund Bini, MD, FACP, FACG, Lynn Bradley, PA, Robert Dufour, MD, Judith Feldman, MD, MPH, Katherine P. Frandsen, RN, CIC, Curt Hagedorn, MD, Rhonda Jankovich, RN, BSN, Karen Jones, Linda Jones, MSN-RN, Stephen Kendall, Daniel Kivlahan, PhD, Kathy Lockhart, RN, MSN, MPA, Thomas Mahl, MD, Robert McNamara, Shvawn McPherson-Baker, PhD, Timothy Morgan, MD, Linda Rabeneck, MD, David Rimland, MD, Gary Roselle, MD, Hugo Rosen, MD, Kimberly Summers, PhD, and Michael Valentino, RPh.

Dr. Wright has led development of the treatment recommendations since their inception. She and Dr. Yee are the lead authors of this version.